RY 143.01 0.4707% TD 77.6 0.2584% SHOP 80.13 1.187% CNR 170.66 -1.1068% ENB 50.38 -0.2376% CP 109.77 -1.0546% BMO 129.61 0.4962% TRI 231.2 0.9254% CNQ 103.4 -0.0966% BN 60.925 0.0082% ATD 76.82 0.774% CSU 3654.1299 0.2772% BNS 66.09 0.8546% CM 67.03 0.2093% SU 53.6 0.1869% TRP 52.96 0.2461% NGT 58.66 1.0334% WCN 225.8 -0.1194% MFC 35.545 0.1268% BCE 47.01 0.7933%

Big Pharma Split Corp Class A

Financial Services CA PRM

14.29CAD
0.48(3.48%)

Last update at 2024-05-15T19:04:00Z

Day Range

14.1914.29
LowHigh

52 Week Range

12.4315.03
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 3.15M 4.85M 0.27M 3.14M 2.78M
Minority interest - - - - -
Net income 3.15M 4.85M 0.27M 5.83M -0.38855M
Selling general administrative 0.36M 0.37M 0.22M 0.29M 0.32M
Selling and marketing expenses - - - - -
Gross profit 3.71M 5.36M 0.59M 2.20M 2.96M
Reconciled depreciation - - - - -
Ebit - 4.61M 0.27M 3.14M 5.95M
Ebitda 3.15M 4.85M 0.27M 0.45M 9.12M
Depreciation and amortization - - - - 3.17M
Non operating income net other - - - - -
Operating income 3.15M 4.85M 0.27M 0.45M 5.95M
Other operating expenses 0.57M 0.51M 0.32M 0.63M 0.73M
Interest expense - 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - -2.68964M 3.17M
Total revenue 3.71M 5.36M 0.59M 2.43M 3.23M
Total operating expenses 0.57M 0.51M 0.32M 0.40M 0.45M
Cost of revenue - - - 0.24M 0.27M
Total other income expense net - - - 2.69M -3.16863M
Discontinued operations - - - - -
Net income from continuing ops 3.15M 4.85M 0.27M 3.14M 2.78M
Net income applicable to common shares - 4.21M -0.21739M 2.58M 2.10M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 39.10M 37.81M 22.93M 27.18M 33.63M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - 0.81M 0.04M 0.24M -
Total liab 19.37M 15.41M 0.21M 10.87M 14.79M
Total stockholder equity 19.73M 22.40M 13.19M 16.31M 18.84M
Deferred long term liab - - - - -
Other current liab -0.34784M -0.33902M -0.21322M 10.87M 14.48M
Common stock - 22.40M 13.19M 16.31M 18.84M
Capital stock - - - - -
Retained earnings - - - - -
Other liab - - - - -
Good will - - - - -
Other assets - 0.15M 0.15M - -33.14380M
Cash 0.82M 1.43M 0.23M 0.54M 0.42M
Cash and equivalents - - - - -
Total current liabilities 0.35M 0.34M 0.21M 10.87M 14.79M
Current deferred revenue - - - - -
Net debt -0.81921M -1.42982M -0.23099M -0.53606M -0.41707M
Short term debt - - - 26.33M 33.14M
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity - 22.40M - - 18.84M
Property plant equipment - - - - -
Total current assets 14.82M 1.53M 0.34M 27.18M 33.63M
Long term investments 24.27M 36.13M 22.45M - 33.14M
Net tangible assets - 22.40M 13.19M 16.31M 18.84M
Short term investments - - - 26.33M 33.14M
Net receivables 14.00M 0.10M 0.10M 0.07M 0.07M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.35M 0.34M 0.21M - 0.31M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -24.27309M -36.13086M -22.44624M 0.00000M -33.14380M
Deferred long term asset charges - - - - -
Non current assets total 24.27M 36.13M 22.45M 0.00000M 33.14M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments - - - - -
Change to liabilities - 0.00000M 0.00000M 0.00000M 0.00000M
Total cashflows from investing activities - - - - -
Net borrowings - - - - -
Total cash from financing activities -1.73730M 10.19M -4.65203M -8.56934M -2.70952M
Change to operating activities - -0.15429M -0.03168M -0.00301M -0.05396M
Net income 2.39M 4.21M -0.21739M 2.58M 2.10M
Change in cash -0.61061M 1.20M -0.30506M 0.12M -1.42845M
Begin period cash flow 1.43M 0.23M 0.54M 0.42M 1.85M
End period cash flow 0.82M 1.43M 0.23M 0.54M 0.42M
Total cash from operating activities 1.13M -9.00036M 4.35M 8.68M 1.27M
Issuance of capital stock 0.88M 13.32M - - 0.00000M
Depreciation - - - - -
Other cashflows from investing activities - - - - -
Dividends paid 2.62M 2.84M 1.73M 2.08M 2.25M
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - - -2.92095M -6.48549M -0.45609M
Other cashflows from financing activities 0.48M 5.46M -0.29107M -0.29107M -0.29107M
Change to netincome - -13.05582M 4.60M 6.10M -0.78022M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.18M -0.15429M -0.03168M -0.00301M -0.05396M
Stock based compensation - - - - -
Other non cash items -1.43645M -13.05582M 4.60M 6.10M -0.78022M
Free cash flow 1.13M -9.00036M 4.35M 8.68M 1.27M

Fundamentals

  • Previous Close 13.81
  • Market Cap17.63M
  • Volume3900
  • P/E Ratio-
  • Dividend Yield8.59%
  • Revenue TTM2.65M
  • Revenue Per Share TTM1.92
  • Gross Profit TTM 5.56M
  • Diluted EPS TTM-0.24

Peer Comparison

Sector: Financial Services Industry: Asset Management

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
PRM
Big Pharma Split Corp Class A
0.48 3.48% 14.29 - - 6.65 1.01 -2.4541
BN
Brookfield Corporation
0.005 0.0082% 60.92 - 9.54 0.86 1.53 3.88 14.06
BAM
Brookfield Asset Management Ltd
0.05 0.09% 54.58 648.13 26.60 5.00 6.91 11.10 9.74
IGM
IGM Financial Inc.
-0.1 0.27% 37.00 8.85 9.56 2.14 1.31 4.30 10.58
PHYS
Sprott Physical Gold
0.25 1.00% 25.20 162.54 - 11.16 1.07 0.26 0.66

Reports Covered

Stock Research & News

Profile

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Big Pharma Split Corp Class A

610 Chartwell Road, Oakville, ON, Canada, L6j 4A5

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).